Displaying 69 Germany Pharma companies
 Filter
City
Country
Stage
Business Model
Industry
company score funding investors employees industries biz model city contact
Ariceum Therapeutics

Diagnosis and treatment of hard-to-treat cancers.

50
$24M · Series A Earlybird Venture Capital, Andera Partners, HealthCap 11 to 50 Health Tech, Biotech, Pharma B2B Berlin, Germany •••••••••••@ariceum-therapeutics.com
HMNC Brain Health

Pioneer in precision medicine for psychiatry based in Munich.

43
$10M ALSTIN Capital 11 to 50 Health Tech, Biotech, Deep Tech, Pharma, Manufacturing B2B Munich, Germany •••••••••••@hmnc-brainhealth.com
Aignostics

Platform that uses AI to improve diagnostics in pathology, aiding drug development and clinical research.

43
$5M · Seed High-Tech Gründerfonds, Ascension Ventures, Wellington Partners 11 to 50 Health Tech, AI, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Berlin, Germany •••••••••••@aignostics.com
Qualifyze

Platform ensuring transparent and secure supply chains in life sciences at affordable costs.

39
$12M · Series A HV Capital, Cherry Ventures, H14 11 to 50 AI, Pharma, Business Intelligence B2B, Marketplace Frankfurt, Germany •••••••••••@qualifyze.com
apriwell

Solution against constipation using natural preparations.

39
$3M · Seed Calm/Storm Ventures 1 to 10 Health Tech, Foodtech, Pharma, Manufacturing B2B Berlin, Germany •••••••••••@apriwell.de
XO Life

Platform that connects patients and pharmaceutical companies to improve health outcomes.

39
$2M · Seed Aescuvest 11 to 50 Health Tech, Pharma, Sales and Marketing B2B, Marketplace Munich, Germany •••••••••••@xo-life.com
Emergence Therapeutics

Emergence is a biopharmaceutical company working on novel ADC immunotherapies for cancers with a high unmet need.

37
$99M High-Tech Gründerfonds, Hadean Ventures 1 to 10 Health Tech, Biotech, Pharma, Fitness, Manufacturing B2B Duisburg, Germany •••••••••••@emergencetx.com
Cardior Pharmaceuticals

Platform for discovering and developing medicines to treat and prevent heart disease.

37
$76M BioMedPartners, High-Tech Gründerfonds, Inkef Capital 11 to 50 Health Tech, Biotech, Pharma B2B Hanover, Germany •••••••••••@cardior.de
Climedo

Platform for clinical validation and product surveillance of medical devices and pharmaceutical products.

34
$1M · Pre Seed Nauta Capital 51 to 100 Health Tech, Biotech, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Munich, Germany •••••••••••@climedo.de
Cinference

protein engineering, ML, drug development

29
N/A Entrepreneur First, Picus Capital 1 to 10 Health Tech, Biotech, Deep Tech, Machine Learning, Pharma B2B Berlin, Germany •••••••••••@cinference.bio
Molab

Biotechnology firm leveraging AI to expedite molecule creation.

29
N/A Picus Capital 1 to 10 AI, Biotech, Pharma, Business Intelligence B2B Munich, Germany •••••••••••@molab.ai
Semalytix

Platform that transforms unstructured data into structured, understandable insights.

26
$5M · Series A Fly Ventures, btov Partners 11 to 50 Health Tech, AI, Machine Learning, Pharma, Data and Analytics, Business Intelligence B2B, SaaS Bielefeld, Germany •••••••••••@semalytix.com
FundaMental Pharma

Neuroscience company focused on developing drugs at the preclinical stage.

26
$10M High-Tech Gründerfonds, Coparion Health Tech, Pharma, Manufacturing B2B Heidelberg, Germany •••••••••••@fundamentalpharma.com
Abalos Therapeutics

Developer of new immuno-virotherapies focused on treating cancer.

26
$13M · Series A High-Tech Gründerfonds, Seventure Partners, Coparion 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Essen, Germany •••••••••••@abalos-tx.com
Exciva

German company is a provider of targeted drug rescue program intended to involve pharmaceutical research and development.

26
$10M · Series A Andera Partners 1 to 10 Health Tech, Biotech, Pharma, Manufacturing B2B Heidelberg, Germany •••••••••••@exciva.com
Eleva

Biotechnology company that develops novel biological therapies.

23
$73M 11 to 50 Health Tech, Biotech, Pharma B2B Freiburg, Germany •••••••••••@elevabiologics.com
Affectis Pharmaceuticals

Drugs developer for the treatment of neurodegenerative and neuroinflammatory diseases.

21
$4M · Series B Aescap Venture, EMBL Ventures 11 to 50 Biotech, Pharma B2C Dortmund, Germany •••••••••••@affectis.com
HQS Quantum Simulations

Platform developing quantum algorithms to predict molecular properties for specialty chemicals and pharmaceutical companies.

21
$2M · Seed Quantonation, btov Partners, High-Tech Gründerfonds 1 to 10 Pharma, Manufacturing, Business Intelligence B2B, SaaS Karlsruhe, Germany •••••••••••@quantumsimulations.de
Cardisio

Screening technology that uses artificial intelligence for non-invasive detection of coronary and structural heart diseases.

18
$4M · Seed 11 to 50 Health Tech, Pharma B2B, B2C Frankfurt, Germany •••••••••••@cardis.io
First A

Application offering instant delivery services for local pharmacies.

18
N/A 11 to 50 Health Tech, CPG & Consumer Goods, Pharma, Mobile, Food Delivery, Ecommerce B2C, Marketplace Berlin, Germany •••••••••••@first-a.de
LenioBio

Platform enabling rapid, plant-based, cell-free protein expression for research, development, and production.

17
$13M · Series A 11 to 50 Biotech, Deep Tech, Pharma, Manufacturing B2B Düsseldorf, Germany •••••••••••@leniobio.com
Noscendo

Diagnostics company specializing in identifying infections quickly.

12
N/A Earlybird Venture Capital, High-Tech Gründerfonds, Paua Ventures 11 to 50 Health Tech, Biotech, Pharma B2B Duisburg, Germany •••••••••••@noscendo.com
CEVEC Pharmaceuticals

Therapeutics platform creating proteins and antibodies with human-like glycosylation.

7
N/A 11 to 50 Health Tech, Biotech, Pharma, Manufacturing B2B Cologne, Germany •••••••••••@cevec.com
dr. vivien karl

Cream for moisturizing care against vulva dryness.

7
N/A 11 to 50 Health Tech, Pharma, Manufacturing, Ecommerce B2C Cologne, Germany •••••••••••@vivienkarl.com